03/26/2025
8:30 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
7:07 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
6:32 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:00 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
9:01 AM | Biora Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/29/2024
3:43 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:37 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
10/29/2024
7:28 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:15 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:19 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:21 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for BIOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/29/2024
7:24 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/23/2024
4:24 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
10/11/2024
3:52 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
10/11/2024
7:00 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:40 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/16/2024
3:30 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
09/13/2024
9:37 AM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024
5:02 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
09/03/2024
3:31 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
08/23/2024
4:06 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:08 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:11 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:13 PM | Biora Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/23/2024
4:03 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/21/2024
4:00 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:15 PM | Biora Therapeutics (Subject)
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
| Form SC 13G | |
08/14/2024
8:57 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
8:58 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
08/12/2024
3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:15 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:05 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
8:42 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
07/08/2024
8:15 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
8:00 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
7:21 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:04 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
07/01/2024
5:07 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:30 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:31 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Howe Jill Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Alter Jeffrey D. (Reporting)
Biora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
06/02/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
